a. CDC - This presentation will reinforce the effectiveness of the Guidelines for Infection Control in Dental Health-Care Settings—2003 and review upcoming products to be released later this year.
b. EPA - An overview of EPA’s regulatory authority as it pertains to antimicrobial products (disinfectants) will be provided. The discussion will place emphasis on product claims for the treatment of surfaces contaminated with bacterial biofilm. EPA’s perspective on biofilm methodology, potential label claims, and the technical aspects under consideration for regulatory guidance will be provided during the session.
c. FDA - To help practitioners and industry understand the regulatory framework of the Food and Drug Administration. Particularly the Dental Devices Branch located within the Center for Devices and Radiological Health of the FDA. Participants will also be able to understand the issues that are similar between agencies and how the agencies delegate responsibility for certain regulatory actions. Specific issues that FDA will address include: reuse of medical devices, and infection control issues relative to multi- use dispensers.
d. HRSA - This presentation will provide an overview of the Health Resources and Services Administration (HRSA), an Operating Division of the U.S. Department of Health and Human Services, the primary Federal agency for improving access to health care services for people who are uninsured, isolated or medically vulnerable and will focus on oral health programs and initiatives.
e. OSHA - An overview of OSHA standards with a focus on the Bloodborne Pathogen Standard (29 CFR 1910.1030). Information will include injury/illness data by industry, the top 10 cited standards in general industry, the top 10 cited standards within healthcare settings, and a discussion of the General Duty Clause.